ALX Oncology Gets New CEO as Founder Moves to Top Science Role

By Dean Seal One of ALX Oncology's board members has taken over as chief executive as founder Jaume Pons transitions into a new role as chief scientific...

Related Keywords

Jason Lettmann ,Jaume Pons , ,Article Normal ,Pharmaceuticals ,Cancer Drugs ,Healthcare Life Sciences ,Specialized Drugs Medications ,Management ,Corporate Industrial News ,Senior Level Management ,Political General News ,Sciences Humanities ,Content Types ,Factiva Filters ,C Amp Ampe Industry News Filter ,Synd ,Alx Oncology Holdings ,Alxo ,Corporate ,Industrial News ,Political ,General News ,Sciences ,Humanities ,Healthcare ,Life Sciences ,Specialized Drugs ,Medications ,